We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Gene Signature Shows Promise for Depression Biomarker Testing

By LabMedica International staff writers
Posted on 13 May 2026

Major depressive disorder (MDD) exerts systemic effects that extend beyond mental health, reflecting interplay between the nervous and immune systems. More...

Peripheral inflammation has been associated with central symptoms and with vascular and inflammatory comorbidities. Researchers now report broad dysregulation of synapse-related genes in circulating immune cells from people with depression.

At the University of São Paulo Medical School (FM-USP) in Brazil, investigators performed systems-level transcriptomic analysis of peripheral leukocytes to delineate neuroimmune gene networks. The approach examined synaptic pathways that are active in blood and may mirror processes relevant to neuronal communication. Findings were published in Scientific Reports.

Using more than 3,000 blood samples from public repositories in the United States, Germany, and France, the team identified gene-expression changes in white blood cells from patients with MDD. In total, 1,383 genes were altered, 73 of which were classically linked to synapses, including neurotransmission and the formation of neural connections. An 18‑gene set consistently differentiated depressed patients from individuals without the disorder.

The mapped network also intersected with conditions frequently seen alongside depression, including bipolar disorder, psychoses, anxiety, hypertension, arterial and inflammatory diseases, and psoriasis; associations were also noted with gastrointestinal symptoms, erectile dysfunction, and coronavirus-related complications. The authors further note that the link between peripheral inflammation and central symptoms could inform inflammation‑targeted interventions.

"We mapped this network of genes that drives the interaction between the immune and nervous systems. Depression is a systemic phenomenon, meaning it spreads throughout the entire body. And the immune system is one of the systems that decentralizes this condition, spreading it beyond the central nervous system," says Otávio Cabral-Marques, a professor at FM-USP and coordinator of the research. "For that reason, it's not uncommon for a person with depression to exhibit other symptoms, such as skin inflammation or loss of appetite, for example."

"It's a data science study that still needs to be biologically confirmed, but it opens up interesting possibilities for the future development of a panel to identify genes present in immune system cells circulating in the blood that are involved in depression. Since blood is more accessible than brain tissue, the identified genes serve as biological markers of the presence and severity of depression," says Anny Silva Adri, who conducted the study as part of her doctoral research.

Related Links
University of São Paulo Medical School


New
Gold Member
Automatic Hematology Analyzer
CF9600
Online QC Software
Acusera 24•7
New
Rapid Sepsis Test
SeptiCyte RAPID
New
All-in-One Molecular System
AIO M160
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The addition of pTau 217 complements blood-based approaches for clinical decision-making in neurology workflows. The fully automated format supports scalability on the LUMIPULSE G platform (photo courtesty of Shutterstock)

CE-Marked Blood Biomarker Test Advances Automated Alzheimer’s Diagnostics

Specialized care settings frequently evaluate patients aged 50 years and older who present with signs and symptoms of cognitive decline to determine whether amyloid pathology linked to Alzheimer’s disease... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.